New York biotech company trades $60 million in stock for CBD group

Share this:     New York-based biotech company 22nd Century Group, Inc. said it has started integration with GVB Biopharma after swapping $60-65 million in stock for 100% of the Las Vegas-based CBD … Continue reading New York biotech company trades $60 million in stock for CBD group